BRIEF-Boston Scientific anti-stroke device wins FDA panel backing

Wed Dec 11, 2013 7:06pm EST

Dec 11 (Reuters) - Boston Scientific Corp

* Says US FDA advisory committee votes 13-1 that benefits of Watchman anti-stroke device outweigh risks

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.